Asia Pacific HPV Testing and Pap Test Market Size 2021-2027

Asia Pacific HPV Testing and Pap Test Market By Type (Pap Test and HPV Testing), By Application (Cervical Cancer Screening, and Vaginal Cancer Screening), By Product (Consumables, Instruments, and Services), By End Use (Hospitals & Clinics, Laboratories and Other End Users), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Published Date: June-2021 | Number of Pages: 101 | Format: PDF | Report ID: KBV-15091

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the Asia Pacific HPV Testing and Pap Test Market

Market Report Description

The Asia Pacific HPV Testing and Pap Test Market would witness market growth of 35.1% CAGR during the forecast period (2021-2027).

The broad-scale promotion and awareness activities regarding human papillomavirus (HPV) vaccines have brought a realization that HPV vaccine programs are indispensable in both well-established and emerging countries. The current 2 methods of screening viz. visual inspection with acetic acid (VIA) and DNA testing have obtained relatively low importance and popularity across different countries.

In addition to it, the supportive regulations of the government about cardiac monitoring and a surge in the funding or investment in research & development activities for the development of sophisticated technology would bring new & attractive growth opportunities for the market. Furthermore, in order to conduct different kinds of awareness programs, the government and leading companies are providing hefty funding to the universities for creating advanced technologies to simplify the screening process in order to alleviate the occurrences of last-stage cervical cancer. Thus, these factors are likely to act as catalysts for the growth of the HPV Testing and Pap Test Market during the forecast period.

Cervical carcinoma is one of the highly common and fatal diseases of women, and in India, it represents 16% of total cervical cancer cases around the world. The situation is more disturbing in the rural areas where most of the women are uneducated and unaware of the hazards of cervical cancer. In spite of the presence of national guidelines, the screening coverage in India is terribly low. The cases of cervical cancer are expected to reduce in the country by 2020. There are many aspects contributing to this reduction. The enhancement in the living standard and awareness among women through print and audio-visual media has led to a decrease in the occurrence of cervical cancer.

In addition to it, periodic cervical cytological examination by all sexually active women is the major factor that can slow down the rates of carcinoma cervix. Moreover, awareness for genital health and visiting the hospital at the pre-clinical stage are the supporting factors for the control of carcinoma cervix in urban settings. However, the situation of cancer prevalence is horrible among the women of rural areas. They are socio-economically weal and have low hygienic awareness and many other risk factors like early age marriage and multiple pregnancies. Therefore, like in India, women belonging to rural areas of other countries of this region is expected to boost the demand for HPV Testing and Pap Test in the coming years.

The China market dominated the Asia Pacific Instruments Market by Country 2020, thereby, achieving a market value of $118.8 million by 2027. The Japan market is showcasing a CAGR of 33.2% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 35.3% during (2021 - 2027).

Based on Type, the market is segmented into Pap Test and HPV Testing. Based on Application, the market is segmented into Cervical Cancer Screening, and Vaginal Cancer Screening. Based on Product, the market is segmented into Consumables, Instruments, and Services. Based on End Use, the market is segmented into Hospitals & Clinics, Laboratories and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide HPV Testing and Pap Test Market is Projected to reach USD 7.1 Billion by 2027, at a CAGR of 33.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Hologic, Inc., Quest Diagnostics, Incorporated, Seegene, Inc., Arbor Vita Corporation, Femasys, Inc., and Qiagen N.V.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Pap Test
  • HPV Testing

By Application

  • Cervical Cancer Screening,
  • Vaginal Cancer Screening

By Product

  • Consumables
  • Instruments,
  • Services

By End Use

  • Hospitals & Clinics
  • Laboratories
  • Other End Users

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

HPV Testing and Pap Test Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities